BioCardia Inc expected to post a loss of 18 cents a share - Earnings Preview
BioCardia Inc <BCDA.OQ> expected to post a loss of 18 cents a share - Earnings Preview
BioCardia Inc BCDA.OQ BCDA.O is expected to show no change in quarterly revenue when it reports results on August 12 for the period ending June 30 2026
LSEG's mean analyst estimate for BioCardia Inc is for a loss of 18 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for BioCardia Inc is $15.50, about 1,484.4% above its last closing price of $0.98
This summary was machine generated August 10 at 21:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on BioCardia
See all newsBrief: BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
BioCardia Inc reports results for the quarter ended June 30 - Earnings Summary
BioCardia Q2 net loss narrows on lower R&D costs
Brief: BioCardia, Inc. Q2 Net Income USD -1.613 Million
BioCardia Inc expected to post a loss of 18 cents a share - Earnings Preview